Allyson Roberts
Nurse Practitioner · Draper, UTNPI 1750993341
Payments from drug & device makers
Across 137 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$800
- AbbVie$717
- Novo Nordisk$231
- Lilly USA, LLC$204
- Merck$150
- AstraZeneca$113
- plus $972 from 25 others
What the payments were for
- Consulting fees$80025%
- Food & beverage$2,38775%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
How this compares
$3,187 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 11 | $18,119 |
| FarxigaDapagliflozin Propanediol | 13 | $13,958 |
| Duloxetine Hcl | 29 | $1,124 |
| Levothyroxine Sodium | 82 | $1,070 |
| Liothyronine Sodium | 15 | $849 |
| Omeprazole | 34 | $737 |
| Bupropion XlBupropion Hcl | 19 | $631 |
| Atorvastatin Calcium | 70 | $589 |
| Ibuprofen | 15 | $454 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $451 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $408 |
| Lisinopril | 32 | $395 |
| Ezetimibe | 16 | $387 |
| Quetiapine Fumarate | 19 | $375 |
| Metformin Hcl ErMetformin Hcl | 23 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $22 | $18,11911 claims |
| AstraZenecaFarxiga | $113 | $13,95813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Draper
- Geoffrey OsmondDraper$62K
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$18K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.